Advanced search
Publication Cover
Upsala Journal of Medical Sciences Volume 123, 2018 - Issue 1
Journal homepage
1,156
Views
14
CrossRef citations to date
0
Altmetric
Article

MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death

Chao DingJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; View further author information
,
Su-Ning ChenJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People’s Republic of China; View further author information
,
Roderick A. F. MacleodLeibniz Institute DSMZ–German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany; View further author information
,
Hans G. DrexlerLeibniz Institute DSMZ–German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany; View further author information
,
Stefan NagelLeibniz Institute DSMZ–German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany; View further author information
,
De-Pei WuJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People’s Republic of China; ;Suzhou Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, People’s Republic of ChinaView further author information
,
Ai-Ning SunJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People’s Republic of China; ;Suzhou Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, People’s Republic of ChinaView further author information
&
Hai-Ping DaiJiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, People’s Republic of China; ;Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People’s Republic of China; ;Leibniz Institute DSMZ–German Collection of Microorganisms and Cell Cultures, Braunschweig, Germany; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-1125-7744View further author information
ORCID Icon show all
Pages 19-27 | Received 08 Dec 2017, Accepted 07 Feb 2018, Published online: 01 Mar 2018

References

  • Jourdan E, Boissel N, Chevret S, Delabesse E, Renneville A, Cornillet P, et al. Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemia. Blood. 2013;121:2213–23.
  • Wang YY, Zhou GB, Yin T, Chen B, Shi JY, Liang WX, et al. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec. Proc Natl Acad Sci USA. 2005;102:1104–9.
  • Fazi F, Racanicchi S, Zardo G, Starnes LM, Mancini M, Travaglini L, et al. Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. Cancer Cell. 2007;12:457–66.
  • Nervi C, Fazi F, Grignani F. Oncoproteins, heterochromatin silencing and microRNAs: a new link for leukemogenesis. Epigenetics. 2008;3:1–4.
  • He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522–31.
  • Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259–69.
  • Wu W, Sun M, Zou GM, Chen J. MicroRNA and cancer: current status and prospective. Int J Cancer. 2007;120:953–60.
  • Li Z, Chen J. In vitro functional study of miR-126 in leukemia. Methods Mol Biol. 2011;676:185–95.
  • Shibayama Y, Kondo T, Ohya H, Fujisawa S, Teshima T, Iseki K. Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients. Oncol Rep. 2015;33:2176–82.
  • Li Y, Gao L, Luo X, Wang L, Gao X, Wang W, et al. Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood. 2013;121:499–509.
  • Cheng Y, Wang Y, Wang H, Chen Z, Lou J, Xu H, et al. Cytogenetic profile of de novo acute myeloid leukemia: a study based on 1432 patients in a single institution of China. Leukemia. 2009;23:1801–6.
  • Bacher U, Kern W, Schnittger S, Hiddemann W, Schoch C, Haferlach T. Further correlations of morphology according to FAB and WHO classification to cytogenetics in de novo acute myeloid leukemia: a study on 2,235 patients. Ann Hematol. 2005;84:785–91.
  • Drexler HG. Guide to leukemia-lymphoma cell lines. 2nd ed. [e-book on compact disc] Braunschweig, Germany: 2011.
  • Heidenreich O, Krauter J, Riehle H, Hadwiger P, John M, Heil G, et al. AML1/MTG8 oncogene suppression by small interfering RNAs supports myeloid differentiation of t(8;21)-positive leukemic cells. Blood. 2003;101:3157–63.
  • Nagel S, Hambach L, Krauter J, Venturini L, Heidenreich O, Ganser A, et al. Analysis of the nuclear distribution of the translocation t(8;21)-derived fusion protein AML1/ETO by confocal laser scanning microscopy. J Hematother Stem Cell Res. 2002;11:401–8.
  • Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435:834–8.
  • Zhu X, Lin Z, Du J, Zhou X, Yang L, Liu G. Studies on microRNAs that are correlated with the cancer stem cells in chronic myeloid leukemia. Mol Cell Biochem. 2014;390:75–84.
  • Kovaleva V, Mora R, Park Y, Plass C, Chiramel A, Bartenschlager R, et al. miRNA-130a targets ATG2B and DICER1 to inhibit autophagy and trigger killing of chronic lymphocytic leukemia cells. Cancer Res. 2012;72:1763–72.
  • Suresh S, McCallum L, Lu W, Lazar N, Perbal B, Irvine AE. MicroRNAs 130a/b are regulated by BCR-ABL and downregulate expression of CCN3 in CML. J Cell Commun Signal. 2011;5:183–91.
  • Häger M, Pedersen CC, Larsen MT, Andersen MK, Hother C, Grønbaek K, et al. MicroRNA-130a-mediated down-regulation of Smad4 contributes to reduced sensitivity to TGF-β1 stimulation in granulocytic precursors. Blood. 2011;118:6649–59.
  • Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A, et al. Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory signals independent of p53. Leukemia. 2010;24:89–96.
  • Lee SH, Jung YD, Choi YS, Lee YM. Targeting of RUNX3 by miR-130a and miR-495 cooperatively increases cell proliferation and tumor angiogenesis in gastric cancer cells. Oncotarget. 2015;6:33269–78.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.